Febrile neutropenia (FN)
Clinical trials for Febrile neutropenia (FN) explained in plain language.
Never miss a new study
Get alerted when new Febrile neutropenia (FN) trials appear
Sign up with your email to follow new studies for Febrile neutropenia (FN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new protein drug shield kids with cancer from dangerous infections?
Disease control Recruiting nowThis trial tests whether a new drug called albipagrastim alfa can prevent severe neutropenia (dangerously low white blood cell counts) in children with sarcoma who are receiving chemotherapy. The drug is designed to stimulate the body's production of infection-fighting neutrophil…
Matched conditions: FEBRILE NEUTROPENIA (FN)
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could shorter antibiotic courses be safer for blood cancer patients?
Knowledge-focused Recruiting nowThis study looks at whether blood cancer patients with a serious infection can safely stop antibiotics sooner if they are stable for 72 hours, instead of the usual 10-day course. About 172 adults will be randomly assigned to either a personalized short course or standard long cou…
Matched conditions: FEBRILE NEUTROPENIA (FN)
Sponsor: Valeria Cento • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC